Zhe Jiang

Zhe Jiang


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2015 in Natural Product Research
Verified
Journal Article
Closed access
MJMei Jin
Mei Jin
SDShengbao Diao
Shengbao Diao
CZChanghao Zhang
Changhao Zhang
SCShuo Cao
Shuo Cao
JSJinfeng Sun
Jinfeng Sun
GLGao Li
Gao Li
Two new diarylheptanoids, ( - )-threo-3',4″-epoxy-1-(4-hydroxyphenyl)-7-(3-methoxyphenyl)heptan-2,3-diol (1) and (1α,3β,5α,6α)-1,5-epoxy-3,6-dihydroxy-1,7-bis(3-methoxy-4-hydroxy-phenyl)-heptane (2), along with one known diarylheptanoid, rhoiptelol B (3), were isolated from the roots of Juglans mandshurica. The structures of compounds 1 and 2 were identified based on HR-ESI-MS, 1D and 2D NMR including (1)H-(1)H COSY, HMQC, HMBC and NOESY spectroscopic methods.

13 January 2022 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
HLHuiqin Li
Huiqin Li
SSStephanie A Schroer
Stephanie A Schroer
VVVeronique Voisin
Veronique Voisin
YJYoungJun Ju
YoungJun Ju
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


20 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
MAMichelle Sofia Allkanjari
Michelle Sofia Allkanjari
ECEu Ddeum Chung
Eu Ddeum Chung
HTHanna Tran
Hanna Tran
RARonak Ghanbari Azarnier
Ronak Ghanbari Azarnier
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
Pineoblastoma (PB) is a rare yet lethal pediatric brain cancer of the pineal gland, a small endocrine organ that secretes melatonin to regulate the circadian rhythm. For PB patients ≤5 years of age, the overall survival rate is approximately 15%; metastatic PB is incurable. Standard treatment, including surgical resection, radiation, and systemic chemotherapy, improves survival but compromises neurocognitive function. A better understanding of the disease and the generation of preclinical models may enable re-evaluation of previous clinical trials, development of precision therapeutic strategies and improve patient outcome. Over the past 5 years, PB has been recognized to include several major subtypes driven by (i) loss of microRNA processing factors DICER and DROSHA characterized by a relatively good prognosis; (ii) loss of the retinoblastoma tumor suppressor RB1; and (iii) amplification or induction of the cMYC protooncogene, with the latter two subtypes exhibiting exceedingly poor prognosis. Recently, mouse models for the major PB subtypes (RB1-, DICER1- and DROSHA-) except MYC- have been established. This progress, including better understanding of the disease, cell of origin, tumor progression, role of autophagy, and targetable vulnerabilities, holds promise for novel therapeutic strategies to combat each subtype of this lethal childhood malignancy.

16 April 2026 in British Journal of Cancer
Verified
Journal Article
Closed access
DWDongyu Wang
Dongyu Wang
ZJZhe Jiang
Zhe Jiang
YBYaacov Ben-David
Yaacov Ben-David
SDSusan J Done
Susan J Done
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus

7 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
YJYoung-Jun Ju
Young-Jun Ju
AAAmjad Ali
Amjad Ali
ECEu Ddeum Chung
Eu Ddeum Chung
DWDongyu Wang
Dongyu Wang
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
The metastasis of tumor cells into vital organs is a major cause of death from diverse types of malignancies